ELRIG Drug Discovery 2026 has ended. This guide stays up as the record of who was there. Next: ELRIG DD 2027, Oct 19–20, 2027 in Liverpool

UK Dementia Research Institute at ELRIG Drug Discovery 2026

Oct 14–15, 2026 London, UK ~3k attendees Website

UK Dementia Research Institute takes part in 2 sessions at ELRIG Drug Discovery 2026 in London, its home city. Its program centres on inclusive translational neuroscience drug development. It follows ALS and motor neurone disease therapeutics from high-throughput phenotypic screening through to clinical trials.

OrganizationELRIG Drug Discovery 2026 Attendance
Academic & healthcare
National research institute studying dementia and neurodegenerative disease through centres hosted at UK universities.
Chair
Thu Oct 15
10:50am–10:55am
Track Chair - Inclusive translational approaches to accelerate equitable neuroscience drug development
What it takes to move neurological drugs through clinical trials, from trial design and patient grouping to diverse enrolment and regulatory expectations.
with Northumbria University
Talk
Thu Oct 15
10:55am–11:25am
From High throughput Phenotypic Drug Screening to Clinical Trials: Advancing ALS/MND Therapeutics
Inclusive translational approaches to accelerate equitable neuroscience drug development

Explore the full ELRIG Drug Discovery 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in London. Leave your work email and we’ll be in touch.

Privacy

Download the full ELRIG Drug Discovery 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from UK Dementia Research Institute

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by ELRIG. Submit a correction